Tech Company Financing Transactions

Transport Pharmaceuticals Funding Round

Transport Pharmaceuticals, operating out of Framingham, secured $27 million in investment from Quaker Partners, The Carlyle Group and EGS Healthcare Capital Partners.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

161 Worcester Road 402
Framingham, MA 01701
USA

Phone

(508) 872-0433

Website

www.transportpharma.com

Email Address

[email protected]

Overview

Transport is revolutionizing the treatment of dermal diseases by bringing together cutting edge electronics, drug formulation and materials science to develop novel drug/device combination products.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Dennis Goldberg

        

Vice President

Eric Morrel

        

VP - Operations

Robert Etheredge

        

VP - R & D

Phillip Friden

        

Browse more venture capital transactions:

Prev: 11/22/2004: Xoomsys venture capital transaction
Next: 11/22/2004: Tepha venture capital transaction

Share this article

Where The Data Comes From

We do our best to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary